1.52
Finanzdaten der Aptevo Therapeutics Inc-Aktie (APVO)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Research and Development |
8.40%
3.328
|
3.633 | 3.103 | 3.643 | 3.752 |
| Operating Income/Loss |
3.92%
-6.226
|
-6.48 | -5.213 | -6.024 | -6.983 |
| Income/Loss From Continuing Operations Before Tax |
3.18%
-6.204
|
-6.408 | -5.101 | -5.883 | -6.834 |
| Income/Loss From Continuing Operations After Tax |
3.18%
-6.204
|
-6.408 | -5.101 | -5.883 | -6.834 |
|
|
3.18%
-6.204
|
-6.408 | -5.101 | -5.883 | -6.834 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
49.39%
0.7381
|
1.4585 | 10.55 | 3.5199 | 0.6867 |
| Diluted Average Shares |
49.39%
0.7381
|
1.4585 | 10.55 | 3.5199 | 0.6867 |
| Basic Earnings Per Share |
91.34%
-8.40
|
-4.39 | -0.48 | -1.67 | -9.95 |
| Diluted Earnings Per Share |
91.34%
-8.40
|
-4.39 | -0.48 | -1.67 | -9.95 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):